Repository logo
 

Molecular autopsy by trio exome sequencing (ES) and postmortem examination in fetuses and neonates with prenatally identified structural anomalies.

Simple item page
cam.issuedOnline2018-10-08
dc.contributor.authorQuinlan-Jones, Elizabeth
dc.contributor.authorLord, Jenny
dc.contributor.authorWilliams, Denise
dc.contributor.authorHamilton, Sue
dc.contributor.authorMarton, Tamas
dc.contributor.authorEberhardt, Ruth Y
dc.contributor.authorRinck, Gabriele
dc.contributor.authorPrigmore, Elena
dc.contributor.authorKeelagher, Rebecca
dc.contributor.authorMcMullan, Dominic J
dc.contributor.authorMaher, Eamonn R
dc.contributor.authorHurles, Matthew E
dc.contributor.authorKilby, Mark D
dc.contributor.orcidMaher, Eamonn [0000-0002-6226-6918]
dc.date.accessioned2018-11-20T00:31:14Z
dc.date.available2018-11-20T00:31:14Z
dc.date.issued2019-05
dc.description.abstractPURPOSE: To determine the diagnostic yield of combined exome sequencing (ES) and autopsy in fetuses/neonates with prenatally identified structural anomalies resulting in termination of pregnancy, intrauterine, neonatal, or early infant death. METHODS: ES was undertaken in 27 proband/parent trios following full autopsy. Candidate pathogenic variants were classified by a multidisciplinary clinical review panel using American College of Medical Genetics and Genomics (ACMG) guidelines. RESULTS: A genetic diagnosis was established in ten cases (37%). Pathogenic/likely pathogenic variants were identified in nine different genes including four de novo autosomal dominant, three homozygous autosomal recessive, two compound heterozygous autosomal recessive, and one X-linked. KMT2D variants (associated with Kabuki syndrome postnatally) occurred in two cases. Pathogenic variants were identified in 5/13 (38%) cases with multisystem anomalies, in 2/4 (50%) cases with fetal akinesia deformation sequence, and in 1/4 (25%) cases each with cardiac and brain anomalies and hydrops fetalis. No pathogenic variants were detected in fetuses with genitourinary (1), skeletal (1), or abdominal (1) abnormalities. CONCLUSION: This cohort demonstrates the clinical utility of molecular autopsy with ES to identify an underlying genetic cause in structurally abnormal fetuses/neonates. These molecular findings provided parents with an explanation of the developmental abnormality, delineated the recurrence risks, and assisted the management of subsequent pregnancies.
dc.description.sponsorshipThis publication is part of the PAGE Study and represents independent research commissioned by the Health Innovation Challenge Fund (HICF‐R7‐396), a parallel funding partnership between the Department of Health and Wellcome Trust. The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health or Wellcome Trust. EM acknowledges support from NIHR Cambridge Biomedical Research Centre and a NIHR Senior Investigator Award. The University of Cambridge has received salary support in respect of EM from the NHS in the East of England through the Clinical Academic Reserve.
dc.format.mediumPrint-Electronic
dc.identifier.doi10.17863/CAM.32825
dc.identifier.eissn1530-0366
dc.identifier.issn1098-3600
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/285467
dc.languageeng
dc.language.isoeng
dc.publisherElsevier BV
dc.publisher.urlhttp://dx.doi.org/10.1038/s41436-018-0298-8
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectautopsy
dc.subjectexome sequencing
dc.subjectfetuses
dc.subjectgenetic diagnosis
dc.subjectneonates
dc.subjectAutopsy
dc.subjectCohort Studies
dc.subjectCongenital Abnormalities
dc.subjectExome
dc.subjectFemale
dc.subjectFetal Diseases
dc.subjectFetus
dc.subjectHumans
dc.subjectInfant, Newborn
dc.subjectMale
dc.subjectPregnancy
dc.subjectPrenatal Diagnosis
dc.subjectExome Sequencing
dc.titleMolecular autopsy by trio exome sequencing (ES) and postmortem examination in fetuses and neonates with prenatally identified structural anomalies.
dc.typeArticle
dcterms.dateAccepted2018-08-29
prism.endingPage1073
prism.issueIdentifier5
prism.publicationDate2019
prism.publicationNameGenet Med
prism.startingPage1065
prism.volume21
pubs.funder-project-idWellcome Trust Sanger Institute, Genome Research Limited (PAGE project code S4029)
pubs.funder-project-idDepartment of Health (via National Institute for Health Research (NIHR)) (NF-SI-0616-10035)
rioxxterms.licenseref.startdate2019-05
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1038/s41436-018-0298-8

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
s41436-018-0298-8.pdf
Size:
388.41 KB
Format:
Adobe Portable Document Format
Description:
Published version
Licence
https://creativecommons.org/licenses/by/4.0/
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
DepositLicenceAgreementv2.1.pdf
Size:
150.9 KB
Format:
Adobe Portable Document Format
Download

Collections

Cambridge University Research Outputs